$0.1026
-0.0086-7.73%
Last update: Nov 5, 4:25 PM
Vivos Therapeutics Inc
VVOSNASDAQ
The average analyst price target for Vivos Therapeutics is $3.87, 3453.7% above the current price. Of 3 analysts, 3 rate it Buy. Targets range from $2.50 to $6. The latest change came on Jun 4, 2026, when Ascendiant Capital raised its price target on Vivos Therapeutics from $3 to $3.10 and kept a Buy rating.
Price Target Range — 6 Quarters
Analyst Consensus — 3 Analysts
Rating Trend — Last 9 Months
